18623-11-5

Usage

Uses

Used in Coatings and Polymers Industry:
N-OCTADECYLSILANE is used as a surface modifier for providing hydrophobic and oleophobic properties to coatings and polymers, enhancing their performance and durability.
Used in Glass and Silica Material Treatment:
N-OCTADECYLSILANE is used as a surface treatment agent for glass and silica materials to improve their hydrophobic nature, offering increased resistance to water and oil.
Used in Rubber and Plastics Production:
N-OCTADECYLSILANE is used as a coupling agent in the production of rubber and plastics, improving their adhesion to inorganic materials and contributing to the overall strength and performance of the final product.
Used in Mechanical Systems:
N-OCTADECYLSILANE is used as a lubricant additive in various mechanical systems to reduce friction and wear, thereby increasing the efficiency and lifespan of the machinery.

InChI:InChI=1/C18H37Si/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h2-18H2,1H3

Upstream product

• 3069-42-9 n-octadecyltrimethoxysilane 

Downstream Products

• 1259515-15-5 benzyl(octadecyl)silane 
• 117091-64-2 etoposide phosphate 

Relevant academic research and scientific papers

Iron-Catalyzed Highly Enantioselective Hydrogenation of Alkenes

Here, we reported for the first time an iron-catalyzed highly enantioselective hydrogenation of minimally functionalized 1,1-disubstituted alkenes to access chiral alkanes with full conversion and excellent ee. A novel chiral 8-oxazoline iminoquinoline ligand and its iron complex have been designed and synthesized. This protocol is operationally simple by using 1 atm of hydrogen gas and shows good functional group tolerance. A primary mechanism has been proposed by the deuterium-labeling experiments.

Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents

The present invention concerns a compound of formula (I) wherein: W represents O or NH, Q represents an unbranched or branched, saturated or unsaturated or aromatic, cyclic or acyclic or heterocyclic hydrocarbon radical containing 1 to 30 carbon atoms including or not heteroatom(s), R1 is H, OH, or R1, R2 form together —O—, R3═R4═OMe or R3 and R4 form together —OCH2O—, R is H, C1-C30alkyl or O-protecting group and R6 represents an unbranched or branched, saturated or unsaturated or aromatic, cyclic or acyclic or heterocyclic hydrocarboned radical containing 1 to 30 carbon atoms including or not heteroatom(s), or R and R6 form together —CMe2-, n is 0 to 8, R5 is H, OH, OMe, O—(C1-C30)-alkyl, O-aryl-(C1-C30)-alkyl, O-(C2-C30)-alkenyl, O—(C3-C30)-cycloalkyl or O-aryl, the dotted line is null or forms a double bond depending on the meaning of R1. It also concerns their methods of preparation and their use in treatment of cancers, leukemias, parasites and as reversal agents of harringtonines.

Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents

The present invention concerns a compound of formula (I) wherein: W represents O or NH, Q represents an unbranched or branched, saturated or unsaturated or aromatic, cyclic or acyclic or heterocyclic hydrocarbon radical containing 1 to 30 carbon atoms including or not heteroatom(s), R1is H, OH, or OMe, O-(C1-C30)-alkyl, O-aryl-(C1-C30)-alkyl, O-(C2-C30)-alkenyl, O-(C3-C30)-cycloalkyl or null, and R2is H or OH, or R1and R2form together —O—, R3=R4=OMe or R3and R4form together —OCH2O—, R is H, C1-C30alkyl or O-protecting group and R6represents an unbranched or branched, saturated or unsaturated or aromatic, cyclic or acyclic or heterocyclic hydrocarbon radical containing 1 to 30 carbon atoms including or not heteroatom(s), or R and R6form together —CMe2—, n is 0 to 8, R5is H, OH, OMe, O-(C1-C30)-alkyl, O-aryl-(C1-C30)-alkyl, O-(C2-C30)-alkenyl, O-(C3-C30)-cycloalkyl or O-aryl, the dotted line is null or forms a double bond depending on the meaning of R1. It also concerns their methods of preparation and their use in treatment of cancers, leukemias, parasites and as reversal agents of harringtonines.